Outcomes of Infra-Inguinal Bypass Using the Omniflow II Graft in Diabetic and Nondiabetic Patients
Despite an unfavorable baseline risk profile, diabetic patients had similar graft-related outcomes compared with nondiabetics. The Omniflow II biosynthetic graft appears to be a safe and effective conduit in this high-risk population.
Authors
- Barzi Gareb (ORCID: https://orcid.org/0000-0003-3534-9176)
- Pieter B. Salemans
- Ben R. Saleem (ORCID: https://orcid.org/0000-0002-7679-2791)
- Erik G.J. Vermeulen
- David J. Liesker (ORCID: https://orcid.org/0000-0002-3097-4303)
- Rudolf P. Tutein Nolthenius
- J. R. Van der Vorst
- Daniel Eefting
- Clark J. Zeebregts
- Tijmen W. Kraai
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Albert Schweitzer Ziekenhuis (NL)
- Medisch Centrum Haaglanden (NL)
- Spaarne Ziekenhuis (NL)
- Zuyderland Medisch Centrum (NL)
- Spaarne Gasthuis (NL)
Publication Details
- Journal
- Annals of Vascular Surgery
- Published
- 2026-01-15
- DOI
- https://doi.org/10.1016/j.avsg.2026.01.006
- Primary Topic
- Infectious Aortic and Vascular Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00